FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308461277> ?p ?o ?g. }

• W4308461277 endingPage "350" @default.
• W4308461277 startingPage "343" @default.
• W4308461277 abstract "Previous studies regarding the risk of skin malignancy with NBUVB have been performed in Caucasian patients, but few studies have been conducted in Asians.The aim of the study was to determine the risk of skin cancer in Asian patients with psoriasis and vitiligo receiving NBUVB phototherapy.We performed a 9-year retrospective study including all patients with psoriasis and vitiligo receiving NBUVB (either 311 nm wavelength through cabin phototherapy or 308 nm through excimer lamp phototherapy) at the National Skin Centre. We matched the identification numbers of patients to the National Registry of Diseases Office database and collected data on all skin cancers diagnosed.A total of 3730 patients were included. During the course of the study, 12 cases of skin cancer were diagnosed, of which 10 were basal cell carcinomas, and 2 were squamous cell carcinomas. No cases of melanoma were detected in the study. The age-standardized incidence of skin cancer in psoriasis and vitiligo patients who received phototherapy was 47.5 and 26.5, respectively, which is higher than the incidence of skin cancers in the general population. Risk of skin malignancy was positively correlated with the cumulative (p = .008) and maximum dose of phototherapy (p = .011) as well as previous systemic treatments (p = .006).Limitations include a relatively short follow-up period as well as the lack of quantification of solar exposure.NBUVB phototherapy in Asian skin increases the risk of skin malignancy. The risk of skin malignancy is higher with psoriasis patients, greater cumulative and maximal dose of phototherapy as well as the use of systemic therapy. Despite the increased risk, the absolute number of skin malignancies remains low, especially for vitiligo patients, with no cases of melanoma diagnosed-a reassuring finding that phototherapy remains a safe alternative in the treatment of psoriasis and vitiligo." @default.
• W4308461277 created "2022-11-12" @default.
• W4308461277 creator A5026309553 @default.
• W4308461277 creator A5051653967 @default.
• W4308461277 creator A5064137612 @default.
• W4308461277 creator A5085333099 @default.
• W4308461277 creator A5090733136 @default.
• W4308461277 date "2022-11-23" @default.
• W4308461277 modified "2023-10-14" @default.
• W4308461277 title "Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients" @default.
• W4308461277 cites W1598883875 @default.
• W4308461277 cites W1964922474 @default.
• W4308461277 cites W1968431395 @default.
• W4308461277 cites W1969186806 @default.
• W4308461277 cites W1978658735 @default.
• W4308461277 cites W1989121777 @default.
• W4308461277 cites W2006290765 @default.
• W4308461277 cites W2021824432 @default.
• W4308461277 cites W2040255701 @default.
• W4308461277 cites W2052364506 @default.
• W4308461277 cites W2054000096 @default.
• W4308461277 cites W2054678820 @default.
• W4308461277 cites W2058887965 @default.
• W4308461277 cites W2070162139 @default.
• W4308461277 cites W2070576100 @default.
• W4308461277 cites W2080250178 @default.
• W4308461277 cites W2096322385 @default.
• W4308461277 cites W2099161090 @default.
• W4308461277 cites W2099414457 @default.
• W4308461277 cites W2109745257 @default.
• W4308461277 cites W2123368313 @default.
• W4308461277 cites W2127706944 @default.
• W4308461277 cites W2133007977 @default.
• W4308461277 cites W2142421937 @default.
• W4308461277 cites W2146469762 @default.
• W4308461277 cites W2155868057 @default.
• W4308461277 cites W2156657486 @default.
• W4308461277 cites W2169053128 @default.
• W4308461277 cites W2255016499 @default.
• W4308461277 cites W2308140228 @default.
• W4308461277 cites W2324161037 @default.
• W4308461277 cites W2325436451 @default.
• W4308461277 cites W2369700818 @default.
• W4308461277 cites W2405342861 @default.
• W4308461277 cites W26104549 @default.
• W4308461277 cites W2789927019 @default.
• W4308461277 cites W2905561991 @default.
• W4308461277 cites W4233759969 @default.
• W4308461277 doi "https://doi.org/10.1111/phpp.12844" @default.
• W4308461277 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36345565" @default.
• W4308461277 hasPublicationYear "2022" @default.
• W4308461277 type Work @default.
• W4308461277 citedByCount "0" @default.
• W4308461277 crossrefType "journal-article" @default.
• W4308461277 hasAuthorship W4308461277A5026309553 @default.
• W4308461277 hasAuthorship W4308461277A5051653967 @default.
• W4308461277 hasAuthorship W4308461277A5064137612 @default.
• W4308461277 hasAuthorship W4308461277A5085333099 @default.
• W4308461277 hasAuthorship W4308461277A5090733136 @default.
• W4308461277 hasConcept C120665830 @default.
• W4308461277 hasConcept C121332964 @default.
• W4308461277 hasConcept C121608353 @default.
• W4308461277 hasConcept C126322002 @default.
• W4308461277 hasConcept C16005928 @default.
• W4308461277 hasConcept C167135981 @default.
• W4308461277 hasConcept C2777789703 @default.
• W4308461277 hasConcept C2778804307 @default.
• W4308461277 hasConcept C2779399171 @default.
• W4308461277 hasConcept C2779980618 @default.
• W4308461277 hasConcept C2780564577 @default.
• W4308461277 hasConcept C2908647359 @default.
• W4308461277 hasConcept C3019992690 @default.
• W4308461277 hasConcept C61511704 @default.
• W4308461277 hasConcept C71924100 @default.
• W4308461277 hasConcept C72563966 @default.
• W4308461277 hasConcept C88879693 @default.
• W4308461277 hasConcept C99454951 @default.
• W4308461277 hasConceptScore W4308461277C120665830 @default.
• W4308461277 hasConceptScore W4308461277C121332964 @default.
• W4308461277 hasConceptScore W4308461277C121608353 @default.
• W4308461277 hasConceptScore W4308461277C126322002 @default.
• W4308461277 hasConceptScore W4308461277C16005928 @default.
• W4308461277 hasConceptScore W4308461277C167135981 @default.
• W4308461277 hasConceptScore W4308461277C2777789703 @default.
• W4308461277 hasConceptScore W4308461277C2778804307 @default.
• W4308461277 hasConceptScore W4308461277C2779399171 @default.
• W4308461277 hasConceptScore W4308461277C2779980618 @default.
• W4308461277 hasConceptScore W4308461277C2780564577 @default.
• W4308461277 hasConceptScore W4308461277C2908647359 @default.
• W4308461277 hasConceptScore W4308461277C3019992690 @default.
• W4308461277 hasConceptScore W4308461277C61511704 @default.
• W4308461277 hasConceptScore W4308461277C71924100 @default.
• W4308461277 hasConceptScore W4308461277C72563966 @default.
• W4308461277 hasConceptScore W4308461277C88879693 @default.
• W4308461277 hasConceptScore W4308461277C99454951 @default.
• W4308461277 hasIssue "4" @default.
• W4308461277 hasLocation W43084612771 @default.
• W4308461277 hasLocation W43084612772 @default.

• next